All lobbying filings
W STRATEGIES, LLC
W STRATEGIES, LLC filed a Q3 report for DYNE THERAPEUTICS, INC. on October 19, 2026, reporting $40,000 in lobbying income.
Lobbying for DYNE THERAPEUTICS, INC. · A biotechnology company developing nucleic acid therapies for rare diseases.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
1
-
DARREN WILLCOXPreviously held: Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director
Government bodies contacted
2
Lobbying activity
1
Education about access to rare disease therapies.